跳至主要内容
临床试验/TCTR20220607005
TCTR20220607005招募中1 期

Comparison of Clinical Response, Pharmacokinetics and Systems Pharmacology Between Dispersible Form of Levodopa and Mucuna pruriens Powder in Parkinson s disease

ational Research Council of Thailand (NRCT)0 个研究点目标入组 12 人开始时间: 2022年6月7日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • (1)PD patients above 18 years of age
  • (2)Patients who diagnose PD according to UKPDSBB criteria.
  • (3)Patients whose symptoms were stable and medication dosage remained same within 3 months.
  • (4)Patients who had motor complication at least 2 hours per day in awakening time.
  • (5)Patients who had ability to record PD diary.

排除标准

  • (1)Patients who had H&Y stage 5 in off period.
  • (2)Patients who had uncontrolled psychotic symptoms .
  • (3)Patients who had dementia determine by TMSE score < 23.
  • (4)Patients who pregnant
  • (5)Patients who currently use drugs that interfere gastric emptying times
  • (6)Patients who had unstable disease such as heart disease or renal failure
  • (7)Patients who had diabetes
  • (8)Patients who allergy to leguminous plant

研究者

发起方
ational Research Council of Thailand (NRCT)

相似试验